Truist Securities Reiterates Hold Rating on Veeva Systems (VEEV)

Truist Securities analyst Joe Meares reiterated a Hold rating and $207.00 price target on Veeva Systems (NYSE: VEEV).

The analyst commented: "Veeva Systems will report its FY3Q25 earnings on Thursday 12/5 after the close. Given the directional color from I-Day and recent favorable commentary from Doximity (DOCS, Hold) from pharma digital advertising perspective and IQVIA (IQV, Buy) from pharma tech & analytics discretionary spend perspective, investor expectations are for a relatively stable print from VEEV. However, with shares up ~14% vs S&P up 8% since last earnings, shares are likely already pricing in for an in-line to slightly better print."

For an analyst ratings summary and ratings history on Veeva Systems click here. For more ratings news on Veeva Systems click here.

Shares of Veeva Systems closed at $227.85 yesterday.

You May Also Be Interested In

• Jones Trading Starts Alterity Therapeutics (ATHE) at Buy
• FDA selects seven participants for precheck pilot program to advance U.S. drug manufacturing
• Hertz Global (HTZ) PT Lowered to $3.50 at Morgan Stanley